The store will not work correctly in the case when cookies are disabled.
We use cookies to make your experience better.To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies.Learn more.
OPEN ACCESS: Wan, Xueshuai et.al. (2024) Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting. Clinical and Molecular Hepatology.
OPEN ACCESS: Wan, Xueshuai et.al. (2024) Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting. Clinical and Molecular Hepatology.
We're sorry, an error has occurred while generating this content.
